Recombinant human monoclonal antibody to Clostridium difficile Toxin A.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate
Unconjugated
Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 145 kDa.
Purity
> 95% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
SDS-PAGE analysis of Actoxumab Biosimilar - Anti-Clostridium difficile Toxin A Antibody - Low endotoxin, Azide free (A323266) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
SEC-HPLC analysis of Actoxumab Biosimilar - Anti-Clostridium difficile Toxin A Antibody - Low endotoxin, Azide free (A323266) confirms that the purity of this antibody is greater than 95%.
Publishing research using Actoxumab Biosimilar - Anti-Clostridium difficile Toxin A Antibody - Low endotoxin, Azide free (A323266)? Please let us know so that we can list the citation on this page.
Alternative products to Actoxumab Biosimilar - Anti-Clostridium difficile Toxin A Antibody - Low endotoxin, Azide free (A323266)
